Offer - Urjas Oil for just ₹ 1
Alrubicin 50 Injection is a prescription drug, available for use as Injection. Breast Cancer are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Alrubicin 50 Injection. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Alrubicin 50 Injection as well, which are listed below. Normally, these side effects of Alrubicin 50 Injection are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Alrubicin 50 Injection has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Alrubicin 50 Injection related warnings talks about Alrubicin 50 Injection's effects on the liver, heart and kidney.
The section on Alrubicin 50 Injection contraindications lists all such conditions.
Additionally, Alrubicin 50 Injection may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Alrubicin 50 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Alrubicin 50 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Geriatric |
|
Is the use of Alrubicin 50 Injection safe for pregnant women?
Alrubicin should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Alrubicin 50 Injection safe during breastfeeding?
Taking Alrubicin may lead to serious side effects if you are breastfeeding. Alrubicin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Alrubicin 50 Injection on the Kidneys?
Kidney can be affected by Alrubicin. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Alrubicin 50 Injection on the Liver?
Alrubicin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Alrubicin 50 Injection on the Heart?
Alrubicin can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Alrubicin 50 Injection unless your doctor advises you to do so -
Is this Alrubicin 50 Injection habit forming or addictive?
Alrubicin 50 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Alrubicin 50 Injection, you should not drive or work on any heavy machine, as Alrubicin 50 Injection can make you drowsy.
Is it safe?
Yes, but take Alrubicin 50 Injection only as per medical advice.
Is it able to treat mental disorders?
No, the use of Alrubicin 50 Injection in mental disorders is not effective.
Interaction between Food and Alrubicin 50 Injection
Taking Alrubicin 50 Injection with food does not harm your health.
Interaction between Alcohol and Alrubicin 50 Injection
Taking alcohol with Alrubicin 50 Injection can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ellence® (epirubicin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 505-508
